CONMED Corporation (CNMD) Social Stream
CONMED CORP (CNMD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CONMED CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 7 | $175 | $155 | $162.166 | $82.85 | 95.73% |
| 2022-01-24 | 6 | $175 | $150 | $160.833 | $82.85 | 94.13% |
| 2022-01-27 | 7 | $175 | $145 | $156.333 | $82.85 | 88.69% |
| 2022-05-06 | 8 | $175 | $145 | $156.142 | $82.85 | 88.46% |
| 2022-06-02 | 7 | $160 | $145 | $155 | $82.85 | 87.09% |
| 2022-07-19 | 6 | $160 | $110 | $144 | $82.85 | 73.81% |
| 2022-08-02 | 6 | $127 | $118 | $122 | $82.85 | 47.25% |
| 2022-10-03 | 6 | $125 | $118 | $121.2 | $82.85 | 46.29% |
| 2022-10-12 | 7 | $125 | $85 | $115.166 | $82.85 | 39.01% |
| 2022-10-14 | 7 | $125 | $85 | $109.666 | $82.85 | 32.37% |
| 2022-10-21 | 7 | $125 | $85 | $105.333 | $82.85 | 27.14% |
| 2022-11-15 | 7 | $108 | $83 | $95.833 | $82.85 | 15.67% |
| 2022-11-16 | 7 | $108 | $83 | $98.5 | $82.85 | 18.89% |
The Trend in the Analyst Price Target
CNMD's average price target has moved up $9.7 over the prior 31 months.
Over the past 42 weeks, CNMD's average upside potential has been 29.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-06 | 8 | 175 | 145 | 157.857 | 116.97 | 34.96% |
| 2022-05-06 | 8 | 160 | 145 | 155.000 | 116.97 | 32.51% |
| 2022-08-10 | 6 | 125 | 118 | 121.200 | 100.85 | 20.18% |
| 2022-10-03 | 6 | 125 | 118 | 121.200 | 81.71 | 48.33% |
| 2022-11-16 | 7 | 108 | 83 | 98.500 | 87.05 | 13.15% |
CNMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 1 | 3 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 13 months, CNMD's average broker recommendation rating worsened by 0.5.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CONMED CORP's average analyst price target is higher than 1381.1% of all US stocks.
- CNMD has a lower variance in analysts' estimates than -159.84% of Healthcare stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, CONMED CORP's upside potential (average analyst target price relative to current price) is higher than 1007.74% of them.
- CONMED CORP's number of analysts covering the stock is higher than 780.3% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to CONMED CORP are SDC, INGN, and AVNS.
View All Top Stocks by Price Target
Is CNMD a Buy, Hold or Sell? See the POWR Ratings now!